Content about Ovarian cancer

February 10, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

ROCKVILLE, Md. — Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health. 

The study was published Feb. 6 in the Journal of the National Cancer Institute.

December 3, 2012

Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

NEW YORK — Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

The study, published in the journal Cancer, enrolled 61 patients who took metformin and 178 who didn't. Of those who took the drug, 67% were surviving after five years, compared with 47% of those who didn't take it. Further analysis indicated that patients taking metformin were almost four times likelier to survive than those not taking it.

September 6, 2012

Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

PARSIPPANY, N.J. — Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

November 3, 2011

L’Oréal Paris and the Ovarian Cancer Research Fund hosted the L’Oréal Paris Legends Gala Wednesday evening at the American Museum of Natural History, uniting the beauty, fashion, finance and media industries to raise funds for ovarian cancer research.

NEW YORK — L’Oréal Paris and the Ovarian Cancer Research Fund hosted the L’Oréal Paris Legends Gala Wednesday evening at the American Museum of Natural History, uniting the beauty, fashion, finance and media industries to raise funds for ovarian cancer research.

L’Oréal Paris spokesperson Julianna Margulies hosted the gala. Kelly Ripa was honored with the OCRF Legends Award. Michael Gordon, founder and COO of Angelo, Gordon & Co., and OCRF benefactor Sally Gordon were honored with the Liz Tilberis Humanitarian Award.

February 9, 2011

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

SOUTH SAN FRANCISCO, Calif. — Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

Genentech, part of Swiss drug maker Roche, announced results from its phase-3 “OCEANS” study, in which women with recurring ovarian cancer received Avastin (bevacizumab) with gemcitabine and carboplatin, both chemotherapy drugs, followed by use of Avastin alone.

February 24, 2010

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

November 6, 2007

L’Oreal Paris is presenting Wednesday evening “A Night of Hope” celebration with Harper’s Bazaar to...

September 11, 2007

French beauty company L'Oreal Paris is commemorating the 10th anniversary of its partnership with The...